The Challenges in Treating Inflammatory Bowel Diseases During the COVID-19 Pandemic: An Opinion.

The Challenges in Treating Inflammatory Bowel Diseases During the COVID-19 Pandemic: An Opinion.

Publication date: Nov 25, 2024

The COVID-19 pandemic posed significant challenges in the treatment of chronic diseases, particularly inflammatory bowel diseases (IBDs) such as Crohn’s disease and ulcerative colitis. These challenges are multifaceted, encompassing difficulties in maintaining routine care, concerns about the safety of immunosuppressive therapies, disruptions in healthcare delivery, and the complexities of managing IBD in patients who contract COVID-19. This article explores the various obstacles faced in the treatment of IBD during the pandemic and discusses potential strategies to overcome these challenges.

Open Access PDF

Concepts Keywords
Colitis COVID-19
Covid Crohn’s disease
Healthcare healthcare challenges
Immunosuppressive inflammatory bowel diseases
pandemic
SARS-CoV-2 infection
treatment
ulcerative colitis

Original Article

(Visited 1 times, 1 visits today)